INIS
cancer
100%
patients
87%
colombia
83%
risks
82%
breasts
81%
genes
80%
diseases
64%
genetics
56%
populations
44%
children
42%
mutations
42%
birth
38%
congenital diseases
38%
control
36%
humans
36%
defects
32%
receptors
30%
levels
29%
data
28%
proteins
22%
surveillance
21%
reviews
21%
mortality
20%
phenotype
20%
blood
19%
women
17%
tissues
16%
newborns
16%
viruses
15%
immunity
15%
hospitals
15%
vaccines
15%
ovaries
15%
estrogens
14%
congenital malformations
14%
lungs
14%
screening
14%
comparative evaluations
14%
hearings
14%
malformations
14%
pregnancy
13%
losses
13%
dna
13%
information
13%
cytokines
12%
adults
12%
tumors
12%
antibodies
12%
protection
12%
spectra
11%
variations
11%
mapping
10%
pediatrics
10%
death
9%
dendrites
9%
carriers
9%
plasma
9%
infants
9%
cities
9%
etiology
9%
males
9%
diarrhea
9%
south america
8%
sex
8%
immunoglobulins
8%
females
8%
nervous system diseases
8%
exons
8%
developing countries
7%
inflammation
7%
mice
7%
symptoms
7%
correlations
7%
regulations
7%
distribution
7%
management
7%
public health
7%
alcohols
7%
rna
7%
in vitro
7%
placenta
7%
chromosomes
7%
nucleotides
7%
latin america
7%
detection
6%
origin
6%
assessments
6%
interactions
6%
mitochondria
6%
promoters
6%
prediction
6%
corrections
6%
evaluation
6%
skin
6%
pathogenesis
6%
therapy
6%
interleukins
6%
apoptosis
6%
lupus
6%
lymphocytes
6%
Medicine and Dentistry
Prevalence
36%
Congenital Malformation
33%
Breast Cancer
30%
Diseases
19%
Rotavirus
15%
Neonatal Infant
15%
Cancer Risk
15%
BRCA1
13%
Infection
13%
Congenital Disorder
11%
Case-Control Study
10%
Odds Ratio
9%
Hearing Impairment
8%
Ovarian Cancer
8%
BRCA2
8%
Diagnosis
7%
Pre-Eclampsia
7%
Health Care
6%
Central Nervous System
6%
Estrogen Receptor
6%
Estrogen Receptor Negative Breast Cancer
5%
Disorders of Sex Development
5%
Hypospadias
5%
Single Nucleotide Polymorphism
5%
Placenta
5%
T Cell
5%
B Cell
5%
Malignant Neoplasm
5%
Neoplasm
5%
Folic Acid
5%